antipyrine has been researched along with Laryngeal Neoplasms in 1 studies
Antipyrine: An analgesic and antipyretic that has been given by mouth and as ear drops. Antipyrine is often used in testing the effects of other drugs or diseases on drug-metabolizing enzymes in the liver. (From Martindale, The Extra Pharmacopoeia, 30th ed, p29)
antipyrine : A pyrazolone derivative that is 1,2-dihydropyrazol-3-one substituted with methyl groups at N-1 and C-5 and with a phenyl group at N-2.
Laryngeal Neoplasms: Cancers or tumors of the LARYNX or any of its parts: the GLOTTIS; EPIGLOTTIS; LARYNGEAL CARTILAGES; LARYNGEAL MUSCLES; and VOCAL CORDS.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lutz, W | 1 |
| SuĊkowski, W | 1 |
| Jakubik, C | 1 |
| Stankiewicz, A | 1 |
1 other study available for antipyrine and Laryngeal Neoplasms
| Article | Year |
|---|---|
Oxidative phenotype as a marker of susceptibility to larynx carcinoma.
Topics: Antipyrine; Biomarkers, Tumor; Humans; Laryngeal Neoplasms; Male; Middle Aged; Oxidation-Reduction; | 1988 |